VIA

Virtus Investment Advisers Portfolio holdings

AUM $296M
1-Year Return 31.42%
This Quarter Return
+9.26%
1 Year Return
+31.42%
3 Year Return
+126.24%
5 Year Return
–
10 Year Return
–
AUM
$296M
AUM Growth
-$72M
Cap. Flow
-$86.7M
Cap. Flow %
-29.31%
Top 10 Hldgs %
6.88%
Holding
512
New
39
Increased
197
Reduced
202
Closed
70

Top Buys

1
CEG icon
Constellation Energy
CEG
$2.01M
2
DASH icon
DoorDash
DASH
$1.82M
3
VEEV icon
Veeva Systems
VEEV
$1.75M
4
CSCO icon
Cisco
CSCO
$1.7M
5
STT icon
State Street
STT
$1.69M

Top Sells

1
VABS icon
Virtus Newfleet ABS/MBS ETF
VABS
$32.2M
2
VSHY icon
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
$24.6M
3
SEIX icon
Virtus SEIX Senior Loan ETF
SEIX
$19M
4
SMC
Summit Midstream Corporation
SMC
$3.67M
5
JNK icon
SPDR Bloomberg High Yield Bond ETF
JNK
$2.09M

Sector Composition

1 Financials 33.24%
2 Healthcare 17.43%
3 Technology 12.41%
4 Industrials 9.1%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
STOK icon
376
Stoke Therapeutics
STOK
$1.15B
$90.3K 0.03%
7,955
-5,368
-40% -$60.9K
ZYME icon
377
Zymeworks
ZYME
$1.14B
$90.1K 0.03%
7,178
-5,828
-45% -$73.1K
ATXS icon
378
Astria Therapeutics
ATXS
$427M
$90K 0.03%
16,792
+57
+0.3% +$306
XENE icon
379
Xenon Pharmaceuticals
XENE
$3.02B
$89.7K 0.03%
2,867
-1,294
-31% -$40.5K
NRIX icon
380
Nurix Therapeutics
NRIX
$758M
$89.5K 0.03%
7,862
-124
-2% -$1.41K
GHRS icon
381
GH Research
GHRS
$869M
$89.3K 0.03%
+7,329
New +$89.3K
IMNM icon
382
Immunome
IMNM
$919M
$89.3K 0.03%
9,605
-2,956
-24% -$27.5K
MRUS icon
383
Merus
MRUS
$5.1B
$89.3K 0.03%
1,698
-2,269
-57% -$119K
UPB
384
Upstream Bio, Inc. Common Stock
UPB
$1.07B
$89.3K 0.03%
+8,134
New +$89.3K
TERN icon
385
Terns Pharmaceuticals
TERN
$634M
$89.2K 0.03%
23,927
-986
-4% -$3.68K
ANAB icon
386
AnaptysBio
ANAB
$621M
$89.2K 0.03%
4,017
-6,909
-63% -$153K
PCVX icon
387
Vaxcyte
PCVX
$4.26B
$88.7K 0.03%
2,729
+857
+46% +$27.9K
CRVS icon
388
Corvus Pharmaceuticals
CRVS
$449M
$88.7K 0.03%
22,177
+1,862
+9% +$7.45K
IDYA icon
389
IDEAYA Biosciences
IDYA
$2.37B
$88.7K 0.03%
4,220
-2,148
-34% -$45.2K
REPL icon
390
Replimune Group
REPL
$491M
$88.4K 0.03%
9,513
-3,921
-29% -$36.4K
DNLI icon
391
Denali Therapeutics
DNLI
$2.26B
$88.1K 0.03%
6,300
-691
-10% -$9.67K
PRAX icon
392
Praxis Precision Medicines
PRAX
$990M
$87.8K 0.03%
2,088
-228
-10% -$9.59K
GPCR icon
393
Structure Therapeutics
GPCR
$1.25B
$87.8K 0.03%
4,232
-945
-18% -$19.6K
BLTE
394
Belite Bio
BLTE
$2.19B
$87.3K 0.03%
1,513
-1,076
-42% -$62.1K
VKTX icon
395
Viking Therapeutics
VKTX
$3.03B
$87.2K 0.03%
3,290
-140
-4% -$3.71K
TYRA icon
396
Tyra Biosciences
TYRA
$674M
$87.1K 0.03%
9,103
-1,715
-16% -$16.4K
KYMR icon
397
Kymera Therapeutics
KYMR
$3.13B
$86.8K 0.03%
1,988
-1,903
-49% -$83K
AVBP icon
398
ArriVent BioPharma
AVBP
$822M
$86.6K 0.03%
3,979
-2,369
-37% -$51.6K
GLUE icon
399
Monte Rosa Therapeutics
GLUE
$306M
$86.2K 0.03%
19,112
-1,961
-9% -$8.84K
MLYS icon
400
Mineralys Therapeutics
MLYS
$2.31B
$85.3K 0.03%
6,302
-7,192
-53% -$97.3K
14 15
16
17 18